Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Copenhagen Stock Exchange  >  H. Lundbeck A/S    LUN   DK0010287234

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo H. Lundbeck A/S
Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases

H. Lundbeck A/S is a pharmaceutical company, which is engaged in the business of research, development, production and sale of pharmaceuticals for the treatment of brain diseases.

The company was founded by Hans Lundbeck on August 14, and is headquartered in Valby, Denmark.

Number of employees : 5 257 persons.
Sales per Businesses
20142015Delta
DKK (in Million)%DKK (in Million)%
Cipralex4,64734.5%---
Other Pharmaceuticals1,98514.7%---
Xenazine1,69512.6%---
Azilect1,49711.1%---
Ebixa1,0587.9%---
Onfi923.006.9%---
Sabril716.005.3%---
Other Revenue547.004.1%---
Treanda212.001.6%---
Brintellix188.001.4%---
Pharmaceuticals--14,594100.9%-
Sales per Regions
20142015Delta
DKK (in Million)%DKK (in Million)%
Rest of Europe4,99137.1%3,86926.7% -22.48%
International4,14430.8%3,82726.5% -7.65%
United States3,75827.9%6,35343.9% +69.05%
Other Revenue547.004.1%518.003.6% -5.3%
Denmark28.000.2%27.000.2% -3.57%
Managers
NameAgeSinceTitle
Kåre Schultz552015President & Chief Executive Officer
Sven Håkan Björklund MD, PhD592011Chairman
Anders Götzsche492007CFO & Executive VP-Information Technology
Anders Gersel Pedersen MD, PhD652000Executive Vice President-Research & Development
Jørn Møller Mayntzhusen, MBA502002Director & Senior Manager-Supply Optimisation
Mona Elisabeth Elster541994Director
Lars Søren Rasmussen572013Independent Director
Terrie Curran472014Independent Director
Henrik Sindal Jensen, PhD472004Director
Lene Skole-Sørensen572015Deputy Chairman
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 197,515,325 59,989,467 30.4% 130,777 0.1% 30.4%
Shareholders
NameEquities%
Lundbeck Foundation 137,351,918 69.6%
Wellington Management Co. LLP 9,866,717 5.00%
OppenheimerFunds, Inc. 3,990,143 2.02%
TIAA-CREF Investment Management LLC 3,475,083 1.76%
Teachers Advisors, Inc. 3,053,631 1.55%
Norges Bank Investment Management 1,963,697 1.00%
Janus Capital Management LLC 1,658,469 0.84%
Nordea Investment Management AB (Denmark) 1,421,642 0.72%
Templeton Global Advisors Ltd. 1,360,460 0.69%
Oddo Meriten Asset Management SA 1,342,609 0.68%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
SANOFI
GLAXOSMITHKLINE P..
ALLERGAN PLC
ELI LILLY AND CO
BAYER AG
ASTRAZENECA PLC
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
-
SHIRE PLC
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
MYLAN NV
SHIONOGI & CO LTD
Sector Pharmaceuticals
H. Lundbeck A/S : Connections
Danish Society of Internal Medicine
Lundbeck Pharma A/S
Fonden Lundbeck International Neuroscience Foundation
Confederation of Danish Industry
Lundbeckfond Invest A/S
Danish Society of Medical Oncology
Atos Medical AB
Rosborg Møbler A/S
American Chamber of Commerce Executives, Inc.
LEGO A/S
Tryg Forsikring A/S
Coloplast Ejendomme A/S
DONG Energy A/S
Lundbeck Cognitive Therapeutics A/S
European Society for Medical Oncology
The British Chambers of Commerce
American Society of Clinical Oncology
Coloplast Danmark A/S
International Association for the Study of Lung Cancer
Company contact information
H. Lundbeck A/S
Ottiliavej 9
Valby, Capital Region 2500

Phone : +45.36.30.13.11
Fax : +45.36.30.19.40
Web : www.lundbeck.com
© 2016 People , Fundamentals and Ownership